Active surveillance: towards a new paradigm in the management of early prostate cancer
- 1 February 2004
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 5 (2) , 101-106
- https://doi.org/10.1016/s1470-2045(04)01384-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate CancerJNCI Journal of the National Cancer Institute, 2003
- Survival prospects after screen‐detection of prostate cancerBJU International, 2002
- Quality of Life after Radical Prostatectomy or Watchful WaitingNew England Journal of Medicine, 2002
- A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2002
- Competing Risk Analysis After Radical Prostatectomy for Clinically Nonmetastatic Prostate Adenocarcinoma According to Clinical Gleason Score and Patient AgeJournal of Urology, 2002
- Feasibility Study: Watchful Waiting For Localized Low To Intermediate Grade Prostate Carcinoma With Selective Delayed Intervention Based On Prostate Specific Antigen, Histological And/Or Clinical ProgressionJournal of Urology, 2002
- DEDIFFERENTIATION OF PROSTATE CANCER GRADE WITH TIME IN MEN FOLLOWED EXPECTANTLY FOR STAGE T1C DISEASEJournal of Urology, 2001
- Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate CancerJAMA, 1998
- EVALUATION OF CHANGES IN PROSTATE SPECIFIC ANTIGEN IN CLINICALLY LOCALIZED PROSTATE CANCER MANAGED WITHOUT INITIAL THERAPYJournal of Urology, 1998
- Prostate specific antigen velocity as a measure of the natural history of prostate cancer: defining a ‘rapid riser’ subsetBritish Journal of Urology, 1998